Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5143630019 | Product containing only tasonermin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5143631015 | Tasonermin only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only tasonermin in parenteral dose form (medicinal product form) | Is a | Product containing tasonermin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only tasonermin in parenteral dose form (medicinal product form) | Is a | Tasonermin only product | true | Inferred relationship | Some | ||
| Product containing only tasonermin in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only tasonermin in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing only tasonermin in parenteral dose form (medicinal product form) | Has active ingredient | Tasonermin (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tasonermin 1 mg powder for solution for infusion vial | Is a | True | Product containing only tasonermin in parenteral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR